These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

2983 related articles for article (PubMed ID: 6693198)

  • 1. Antigen expression in human melanoma cells in relation to growth conditions and cell-cycle distribution.
    Lindmo T; Davies C; Rofstad EK; Fodstad O; Sundan A
    Int J Cancer; 1984 Feb; 33(2):167-71. PubMed ID: 6693198
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of a murine B16 melanoma-associated antigen analyzed by flow cytometry.
    Leong SP; Noguchi PD; Cunningham RE; Ames RS; Speiss PJ; Takami T; Roth JA
    J Surg Res; 1985 Apr; 38(4):383-90. PubMed ID: 3889501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heterogeneous expression of a murine B16 melanoma-associated antigen correlates with cell cycle.
    Leong SP; Noguchi PD; Cunningham RE; Takami T; Roth JA
    Cancer Immunol Immunother; 1987; 24(2):106-12. PubMed ID: 3829045
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cell-cycle-dependent expression of human melanoma membrane antigen analyzed by flow cytometry.
    Leong SP; Bolen JL; Chee DO; Smith VR; Taylor JC; Benfield JR; Klevecz RR
    Cancer; 1985 Mar; 55(6):1276-83. PubMed ID: 3882220
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Compartmental distribution of tumor-specific monoclonal antibodies in human melanoma xenografts.
    Lin K; Nagy JA; Xu H; Shockley TR; Yarmush ML; Dvorak HF
    Cancer Res; 1994 Apr; 54(8):2269-77. PubMed ID: 8174137
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isolation and characterization of the canine melanoma antigen recognized by the murine monoclonal antibody IBF9 and its distribution in cultured canine melanoma cell lines.
    Oliver JL; Wolfe LG; Lopez MK; Church-Bird A; Toivio-Kinnucan M; Dietrich MA
    Am J Vet Res; 1997 Jan; 58(1):46-52. PubMed ID: 8989495
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stable quantitative differences of antigen expression in human melanoma cells isolated by flow cytometric cell sorting.
    Lindmo T; Davies C; Fodstad O; Morgan AC
    Int J Cancer; 1984 Oct; 34(4):507-12. PubMed ID: 6386700
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro properties of human melanoma cells metastatic in nude mice.
    Herlyn D; Iliopoulos D; Jensen PJ; Parmiter A; Baird J; Hotta H; Adachi K; Ross AH; Jambrosic J; Koprowski H
    Cancer Res; 1990 Apr; 50(8):2296-302. PubMed ID: 2156614
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heterogeneity of HLA-A,B, Ia-like, and melanoma-associated antigen expression by human melanoma cell lines analyzed with monoclonal antibodies and flow cytometry.
    Burchiel SW; Martin JC; Imai K; Ferrone S; Warner NL
    Cancer Res; 1982 Oct; 42(10):4110-5. PubMed ID: 7049355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A human melanoma cell line established from xenograft in athymic mice.
    Tveit KM; Fodstad O; Johannessen JV; Olsnes S
    Br J Cancer; 1980 May; 41(5):724-33. PubMed ID: 7426299
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in antigen expression on human FME melanoma cells after exposure to photoactivated hematoporphyrin derivative.
    Davies CD; Western A; Lindmo T; Moan J
    Cancer Res; 1986 Dec; 46(12 Pt 1):6068-72. PubMed ID: 3779629
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A new Mr 55,000 surface protein implicated in melanoma progression: association with a metastatic phenotype.
    Boukerche H; Baril P; Tabone E; Bérard F; Sanhadji K; Balme B; Wolf F; Perrot H; Thomas L
    Cancer Res; 2000 Oct; 60(20):5848-56. PubMed ID: 11059782
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in antigen expression on human FME melanoma cells after exposure to hypoxia and acidic pH, alone or in combination.
    Davies CL; Pettersen EO; Lindmo T
    Int J Cancer; 1989 Feb; 43(2):350-5. PubMed ID: 2645223
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A quantitative analysis of tumor specific monoclonal antibody uptake by human melanoma xenografts: effects of antibody immunological properties and tumor antigen expression levels.
    Shockley TR; Lin K; Sung C; Nagy JA; Tompkins RG; Dedrick RL; Dvorak HF; Yarmush ML
    Cancer Res; 1992 Jan; 52(2):357-66. PubMed ID: 1728407
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Flow cytometric determination of the frequency and heterogeneity of expression of human melanoma-associated antigens.
    Berd D; Herlyn M; Koprowski H; Mastrangelo MJ
    Cancer Res; 1989 Dec; 49(23):6840-4. PubMed ID: 2582430
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antigenic heterogeneity of clones and subclones from human melanoma cell lines demonstrated by a panel of monoclonal antibodies and flow microfluorometry analysis.
    Cillo C; Mach JP; Schreyer M; Carrel S
    Int J Cancer; 1984 Jul; 34(1):11-20. PubMed ID: 6746112
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fluctuations in the expression of a glycolipid antigen associated with differentiation of melanoma cells monitored by a monoclonal antibody, Leo Mel 3.
    Werkmeister JA; Triglia T; Mackay IR; Dowling JP; Varigos GA; Morstyn G; Burns GF
    Cancer Res; 1987 Jan; 47(1):225-30. PubMed ID: 3791209
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiolocalization of xenografted human malignant melanoma by a monoclonal antibody (9.2.27) to a melanoma-associated antigen in nude mice.
    Hwang KM; Fodstad O; Oldham RK; Morgan AC
    Cancer Res; 1985 Sep; 45(9):4150-5. PubMed ID: 4028007
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metastatic potential of human melanoma cells in nude mice--characterisation of phenotype, cytokine secretion and tumour-associated antigens.
    Schadendorf D; Fichtner I; Makki A; Alijagic S; Küpper M; Mrowietz U; Henz BM
    Br J Cancer; 1996 Jul; 74(2):194-9. PubMed ID: 8688321
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isolation and characterization of a heterodimeric surface antigen on human melanoma cells and evidence that it is the 4F2 cell activation/proliferation molecule.
    Dixon WT; Sikora LK; Demetrick DJ; Jerry LM
    Int J Cancer; 1990 Jan; 45(1):59-68. PubMed ID: 2404879
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 150.